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ABSTRACT
Cell type-specific gene expression is regulated by
chromatin structure and the transcription factors
provided by the cells. In the present study, we
introduced genes packaged into chromatin into
target cells using a human artificial chromosome
(HAC) and analyzed regulation of gene expression.
The human b-globin gene cluster was built into an
HAC (globin-HAC) and introduced into mouse
embryonic stem (ES) cells using microcell-mediated
chromosome transfer (MMCT); the adult-type
human b-globin gene was expressed in bone
marrow and spleen cells of the transgenic mice.
In vitro differentiation of ES cells into mouse
erythrocytes indicated that the natural sequential
expression of e, c and b-globin genes was
reproduced on the globin-HAC. Combination of
MMCT and a novel chromosome transfection tech-
nique allowed transfer of globin-HAC from HT1080
cells into the human leukemia cell line K562, and
from K562 cells back into HT1080 cells. Expression
of the c-globin gene, repressed in HT1080 cells, was
activated in K562 cells without any processes of dif-
ferentiation into adult erythroid cells, and was
completely repressed again in HT1080 cells when
transferred back from K562 cells. Thus, transfer of
target genes packaged into chromatin using a HAC
was useful for functional analyses of gene
regulation.
INTRODUCTION
The potency of transcriptional activation can be regulated
by re-organization of chromatin structure and the associ-
ation of transcriptional activators in the regulatory
regions of the genes. It has been assumed that the DNA
of transgenes introduced into cells could be functionally
formed into active chromatin in the cells and that
transgenes introduced into mouse embryonic stem (ES)
cells could be activated through diﬀerentiation.
However, the expression of transgenes integrated into
chromosomes in cultured cells and in transgenic mice is
often subject to position eﬀects.
In previous work, chromosome manipulation technol-
ogy in combination with microcell-mediated chromosome
transfer (MMCT) enabled us to introduce chromosome
fragments into target cells and to reproduce tissue-speciﬁc
gene expression (1–4). Human artiﬁcial chromosomes
(HACs) were constructed using a bottom-up strategy
based on the transfection of cloned or synthetic centro-
meric alphoid DNA precursors with CENP-B boxes into
a cultured human cell line, HT1080 (5–10). The HACs
were built up to megabase size (1–10Mb) by multi-
merization of alphoid precursors. The generation of
bottom-up HACs via multimerization resulted in the
development of HACs intomini-chromosomes carrying
large genomic regions that contain genes and their regu-
latory elements, such as the human guanosine triphos-
phate cyclohydrolase I (GCH1) and the globin cluster
(11,12). Recently, we developed a chromosome vector
that allowed the introduction of transgenes into several
cell lines and the reproduction of tissue-speciﬁc expression
according to the genetic sequences (13). Due to the
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HACs, the method for their transfer into target cells was
limited to MMCT (14,15). HACs have been transferred
successfully into many vertebrate cell lines by MMCT and
are stably transferred during mitosis (13). We have used
MMCT to establish mouse ES cell lines carrying the HAC,
and then created mice that harbour the HAC (12). The
HACs carrying GCH1 or the globin cluster (globin-HAC)
were mitotically stable in mouse ES cells and the HACs
were transmittable in mice.
Considerable amounts of data on regulation of the
human b-globin locus are available. The human b-globin
gene cluster is composed of ﬁve functional genes (e,G g,
Ag, d and b) that are arrayed on chromosome 11 in the
order in which they are developmentally expressed. The
genes are ﬂanked by a group of DNase I hypersensitive
sites known as the locus control region (LCR) upstream
and a downstream hypersensitive site (30HS1). A number
of groups have reproduced the architecture of the human
b-globin locus in transgenic mice using cosmid, yeast
artiﬁcial chromosome (YAC) and bacterial artiﬁcial
chromosome (BAC) constructs (16–19). Using these
large constructs, the high-level tissue and developmental
stage-speciﬁc globin gene expression of the human
b-globin locus were recapitulated in mice. Integration of
the entire b-globin locus containing the LCR into the
mouse genome resulted in authentic expression of the
globin genes independent of the site of integration and
dependent on the number of integrated copies (20–22).
Thus, the b-globin gene locus is a good model for
manipulating and evaluating gene expression and the
reproduction of functional chromatin on a HAC.
In the present study, we established a technology that
can be used to analyze the regulation of expression of
genes built into a HAC. Reproduction of the tissue-
speciﬁc and development-speciﬁc expression of human
globin genes was demonstrated using globin-HAC in
transgenic mice and in vitro-diﬀerentiated mouse erythro-
cytes. The regulation of globin genes was further analyzed
by transferring globin-HAC from HT1080 cells into K562
cells, and from K562 cells back into HT1080 cells.
MATERIALS AND METHODS
Cell culture
HT1080, HeLa and A9 cells were grown in Dulbecco’s
Modiﬁed Eagle Medium (DMEM) supplemented with
10% fetal bovine serum (FBS). K562 cells were grown in
RPMI1640 supplemented with 10% FBS. The ES cell lines
TT2 and TT2F were maintained on feeder cells in ES
cell medium consisting of DMEM supplemented with
20% Knockout SR (Invitrogen), 1000U/ml ESGRO
(Chemicon) and 0.1mM b-mercaptoethanol.
Microcell-mediated chromosome transfer
MMCT from HT1080 to K562 or ES cells was carried out
as described previously (12). Microcells from HT-A9/
globin29 were recovered and fused with K562 cells.
K562 cells containing the HAC were selected in
RPMI1640 supplemented with 6mg/ml blasticidin S.
Preparation of chromosomes
Metaphase chromosomes from K562/globin29 cells were
prepared by a polyamine (PA) procedure according to
(23). K562/globin29 cells were arrested in metaphase for
18h using 0.1mg/ml colcemid in culture medium. Mitotic
cells were then swelled in 75mM KCl for 10min at room
temperature. The cells were then washed in PA buﬀer
(15mM Tris–HCl, pH 7.4; 0.2mM spermine; 0.5mM
spermidine; 2mM EDTA; 0.5mM EGTA; 80mM KCl;
and 20mM NaCl) and then resuspended in cold PA
buﬀer containing 0.1% digitonin. To release the chromo-
somes, the swollen cells were passed through a 27-gauge
needle attached to a 10ml syringe.
Chromosome transfection
HT1080 and HeLa cells were transfected using FuGENE
HD (Roche) according to the instructions. At the time
of transfection, the number of recipient cells per well
was 1.0–1.2 10
6 cells. One million HACs in 100mlP A
buﬀer were combined with the transfection reagents.
Stable transfectants were screened by G418 resistance at
400mg/ml.
Fluorescent in situ hybridization
Fluorescent in situ hybridization (FISH) analysis was
carried out according to conventional procedures. To
detect HACs, biotin-labeled a21-I alphoid DNA (11-4)
(24) and digoxigenin-labeled pYAC2 were used as
probes. Globin genes were detected with biotin-labeled








For dual FISH, biotin-labeled DNA was visualized with
FITC-conjugated avidin (Vector), and digoxigenin-labeled
DNA was visualized with TRITC-conjugated anti-
digoxigenin antibody (Roche Applied Science).
Pulsed-ﬁeld gel electrophoresis and Southern analysis
Agarose-embedded DNA was prepared as previously
described (24). DNA in agarose blocks was digested
with KpnI for 2h and size separated by 1% GTG
agarose gel (Cambrex) using the CHEF mapper system
(Bio-Rad). The running conditions were dependent on
the auto algorithm for 5–70kb. Genomic DNA was
digested with EcoRI and size separated in a 1% GTG
agarose gel in conventional gel electrophoresis. DNA in
the gel was transferred to a nylon membrane and
hybridized with
32P-labeled DNA probes prepared from
human globin gene sequences (50HS5 and introns of
e,G g, and b-globin DNA) produced by PCR using
the following primers: 50HS5, 50-GCATCCTGACACAT
ATGACA-30 and 50-ATCCAGTCATAAGCACAG
AC-30; e globin, 50-GGTGAGTTCAGGTGCTGGTGA
TGTG-30 and 50-CAGGCATGTTGAGTAGAAGTTTC
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GCAC-30 and 50-GATGAACCCATAGTGAGCTGAGA




Total RNA (25ng) was used for reverse transcriptase–
PCR (RT–PCR) using the One Step RNA PCR Kit
(AMV) (TaKaRa). For human e-globin, the primers
were he(sen) 50-CAATCACTAGCAAGCTCTCAGG-30
and he(anti) 50-GGGCTTGAGGTTGTCCATGTTT-30.
For human g-globin, the primers were hg(sen) 50-GATG
CCATAAAGCACCTGGATG-30 and hg(anti) 50-TTGC
AGAATAAAGCCTATCCTTGA-30. For human
b-globin, the primers were hb(sen) 50-AACTGTGTTCA
CTAGCAACCTCAA-30 and hb(anti) 50-GAGTGGACA
GATCCCCAAAGGA-30. The ampliﬁcation conditions
were 50 C for 30min, 94 C for 2min, followed by 25
cycles of 94 C for 30s, 55 C for 30s and 72 C for 30s.
The primers for ey, b-major and GATA-1 were reported
previously (25); the samples were ampliﬁed at 50 C for
30min and 94 C for 2min, followed by 25 cycles of
94 C for 20s, with a ramp time of 1min, 55 C for 1s
and 72 C for 1min.
Real-time PCR
Genomic DNA from HAC-containing cells was extracted
according to standard procedures. Total RNA was
prepared using SV Total RNA Isolation System
(Promega). cDNA was synthesized using Transcriptor
First Strand cDNA Synthesis Kit (Roche Applied
Science). Real-time PCR was carried out using ABI
PRISM 7700 Sequence Detection System (Applied
Biosystems). PCR reactions were carried out using the
QuantiTect SYBR Green PCR kit (Qiagen) and
Power SYBR Green PCR Master Mix (Applied












ACAA-30; and b-actin: 50-ATCTGGCACCACACCTTC
TACAATGAGCTGCG-30 and 50-GTCATCTTTTCAC
GGTTGGCCTTAGGGTTCAG-30.
Threshold cycles of PCR reactions were determined in
triplicate using the following conditions: 40 cycles of 94 C
for 15s, 60 C for 30s and 72 C for 30s.
In vitro diﬀerentiation of embryonic stem cells
Mouse ES cells were diﬀerentiated into hematopoietic cells
in vitro using methods reported previously, with some
modiﬁcations (25). The ES cells were seeded at 4 10
4
onto conﬂuent OP9 cells (RIKEN cell bank) in a 6-cm
dish and cultured in a-MEM medium (Invitrogen) supple-
mented with 20% FBS, 2U/ml erythropoietin (Roche
Applied Science), and 100ng/ml recombinant mouse
stem cell factor (R&D Systems). After 5 days in culture,
the cells were dissociated and seeded onto fresh OP9 layers
in the same culture medium. Both ﬂoating and adherent
cells were harvested after 3, 6 and 9 days.
RESULTS
Transfer of the human b-globin gene cluster using
an HAC
The human b-globin gene cluster packaged into chromatin
(globin-HAC) was previously constructed by HAC tech-
nology using YACs 7C5hTEL and A201F4.3 in HT1080
cells (Figure 1a) (12). The globin-HAC in HT1080 cells
(HT/globin29) was mitotically stable (Figure 1b). To
analyze cell type-speciﬁc expression of the globin gene
cluster packaged into chromatin, the globin-HAC was
transferred into human K562 leukemia cells by MMCT;
in addition, the globin-HAC was previously transferred
into mouse ES cells (TT2 and TT2F) (12). The presence
of globin-HAC in the K562 cell lines was conﬁrmed by
FISH analysis (Figure 1b).
The integrity of the globin gene clusters in TT2/
globin29-2 and K562/globin29 was analyzed by
Southern hybridization and real-time PCR (Figure 1c).
Genomic DNA from HT/globin29, TT2/gobin29-2 and
K562/globin29 was digested with EcoRI or KpnI and
hybridized using 50HS5, e,A g,G g and b-globin as
probes (Figure 1c). The EcoRI 3.4-kb fragment, 50HS5
and KpnI 14-kb and 40-kb fragments were detected as
added signal intensities relative to the signals from
HT1080 cells. Quantitative real-time PCR analysis indi-
cated that the globin genes on the HACs existed in
12 copies in K562/globin29, which is about the same as
the number of copies in HT/globin29 cells (12). These
results indicated that after transfer, the globin-HAC main-
tained its internal structure in K562 and mouse ES cells.
Using the MMCT technique, it is not possible to
transfer HACs from donor cells that cannot form
microcells, including K562 cells. We established an alter-
native transfer technology for isolation and transfection of
HACs into target cell lines. We isolated HACs from
metaphase cells by simple 25% sucrose cushion centri-
fugation under polyamine buﬀer conditions. Transfer
of HACs into target cell lines was achieved using conven-
tional transfection reagents, which enabled direct transfer
of the HAC from a variety of donor cells, including those
that could not form microcells (Figure 2a). The eﬃciency
of chromosome transfection (number of transformants/
number of recipient cells) was 1.1–8.7 10
 5. Using this
procedure, we successfully transferred the globin-HAC
from K562 cells into target cells (Figure 2b).
Tissue-speciﬁc expression of human globin genes from
the HAC in mice
To examine tissue-speciﬁc gene expression of globin genes
from the globin-HAC in mice, we produced chimeric mice
PAGE 3 OF 9 Nucleic AcidsResearch, 2010, Vol.38,No. 5 e33Figure 1. Properties of the globin-HAC. (a) Schematic representation of the precursor YACs. The 7C5hTEL is composed of an 80-kb a21-I array,
the selection marker SV-bsr, and human telomeres. The A201F4.3 contains 130kb of the entire human b-globin locus (e,G g,A g, d and b) and the
locus control region (LCR). The bars indicate the EcoRI and KpnI restriction fragments and their sizes. (b) Characterization of the globin-HAC in
HT1080 and K562 cells. HT1080 cells carrying the globin-HAC (HT/globin29) and K562 cells carrying the globin-HAC (K562/globin29) were
analyzed by FISH using YAC vector, alphoid DNA and globin genes as probes. Arrowhead indicates the globin-HAC. (c) Integrity analysis of the
globin locus in the globin–HAC by Southern hybridization. Genomic DNA from HT1080, HT/globin29, TT2/globin29-2, TT2 and K562/globin29
cells was digested with EcoRI or KpnI; 50HS5, e-, Gg-, b-globin were used as probes.
Figure 2. Transfer of the HAC by chromosome transfection. (a) Scheme of chromosome transfection. HACs were collected from metaphase cells,
isolated by centrifugation using sucrose cushion and transfected into target cells using lipofection reagents. The red shapes show HACs and blue
shapes show nuclei or metaphase cellular chromosomes. (b) FISH analysis of the globin-HAC in HeLa/globin-vK cells. Metaphase chromosomes of
HeLa/globin-vK cells were probed using alphoid DNA (green) and YAC vector DNA (red).
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carrying the globin-HAC were obtained by crossing the
chimeric mice created using TT2/globin29-2 cells (12).
FISH analysis using metaphase chromosomes from the
F1 mice revealed that the globin-HAC was maintained
in the tail, bone marrow, and spleen cells at 90%, 98%
and 96%, respectively (Figure 3a). RT–PCR and quanti-
tative real-time PCR analyses showed that the human
adult-type b-globin gene was expressed in bone marrow
and spleen, but not in the tail, and that the human e-
and g-globin genes were not expressed in adult tissues
(Figure 3b and c). The expression level of the human
adult-type b-globin gene in an F1 mouse was 14.3- or
15.2-fold higher than that of the mouse b-major globin
in bone marrow or spleen, indicating that high-level
expression was dependent on the globin gene copy
number, as previously reported (Figure 3c) (22). These
results indicate that the natural patterns of tissue-speciﬁc
expression of the human globin genes on the HAC were
mimicked in mice.
Diﬀerentiation-speciﬁc responses of human globin genes in
maturing mouse erythrocytes
Diﬀerentiation-speciﬁc expression patterns of globin genes
could be reproduced by inducing in vitro diﬀerentiation
of ES cells harbouring the globin-HAC into blood cells
(Figure 4) (25). During diﬀerentiation of TT2/globin29-2
and TT2F/globin29 cells into erythrocytes, the mouse and
human globin gene transcripts (ey, b-major, e, g and b)
were detected by RT–PCR (Figure 4a), and the expression
levels were determined by quantitative real-time PCR
(Figure 4b). Expression of endogenous mouse ey and
b-major globin genes in TT2 and TT2F cells was
examined at 5, 8, 11 and 14 days after onset of diﬀerenti-
ation. Peak expression of the ey-globin occurred during
days 8–11, whereas that of the b-major globin occurred
during days 11–14. Under diﬀerentiation conditions,
expression of the human e- and g-globin genes from
the HAC in TT2/globin29-2 and TT2F/globin29
cells also began at day 8 and peaked after 8–11 days
Figure 3. Expression of globin genes from the globin-HAC in mice. (a) FISH analysis of the globin-HAC in tissues (tail, bone marrow and
spleen) from an F1 mouse. The red signal shows YAC DNA and the green signal shows alphoid DNA. Arrowheads indicate the globin-HAC.
(b) Tissue-speciﬁc expression of globin genes from the HAC. The globin transcripts from the human and mouse genes were detected by RT–PCR
using total RNA derived from adult mouse tail, bone marrow and spleen. (c) Quantiﬁcation of globin transcripts in an F1 mouse. Expression of
globin genes from bone marrow and spleen was determined by quantitative real-time PCR. Histograms show globin gene transcript quantities in the
presence (+) or absence ( ) of the globin-HAC.
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b-globin began on day 11 and peaked during days 11–14
(Figure 4a and b). These data indicate that the expression
pattern of human e, g and b-globin genes from the HAC
switched in an appropriate stage-speciﬁc manner during
diﬀerentiation into blood cells and correlated with the
expression pattern of the mouse globin genes.
Responses of globin genes to a drastic change in cell type
To analyze the regulation of gene expression in response
to drastic changes in cell type, the expression of globin
genes was compared before and after globin-HAC
transfer (Figure 5a). mRNA transcripts of the Gg- and
Ag-globin genes were detected by RT–PCR using total
RNA from cell lines with or without globin-HACs
(Figure 5b). In the case of transfer from HT1080 to
K562 cells, Gg- and Ag-globin transcripts were not
detected in HT/globin29 cells or in HT1080 cells. The
Gg-globin and Ag-globin transcripts in K562/globin29
cells were 10.7- and 20.7-fold greater than those in the
K562 cells without globin-HAC, as shown by quantitative
real-time RT–PCR (Figure 5b). To analyze the expression
response when transferring globin-HAC from erythrocyte
cells to non-erythrocyte cells, we transferred the globin-
HAC from K562 cells back into HT1080 or HeLa cells
by chromosome transfection. We established eleven
HT1080 and seven HeLa clones carrying globin-HAC
(HT/globin-vK, HeLa/globin-vK). In the case of transfer
from K562 to HT1080 or HeLa, Gg- and Ag-globin
transcripts were not detected in HT/globin-vK or HeLa/
globin-vK cell lines (Figure 5c). These results indicated
that expression of the Gg- and Ag-globin genes from the
HAC was activated in the K562 cells and was repro-
ducibly repressed in non-erythrocyte cell lines.
Figure 4. Expression pattern of globin genes from the globin-HAC in mouse blood cells diﬀerentiated from ES cells. (a) Expression pattern of
human globin genes in diﬀerentiating ES cells. The ﬂoating cells were recovered from TT2F and TT2F/globin29 cells at days 0, 5, 8, 11 and 14 after
induction of diﬀerentiation of ES cells into blood cells. The expression of human e,A g,G g and b-globin genes, and mouse ey, b-major, GATA-1
and b-actin was detected by RT–PCR using total RNA. (b) Expression level of globin genes determined by quantitative real-time PCR. The
histogram shows the quantities (copies/mg RNA) of e-, Gg-, Ag- and b-globin transcripts in TT2 and TT2/globin29-2 cells.
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Genes can be packaged into chromatin using HAC tech-
nology in human HT1080 cells. However, one problem
in manipulating HACs has been the introduction of
the HAC into target cells. The general technique for
introducing chromosomes has been MMCT, in which
donor cells are limited to theminority of cultured cells
that can form microcells. Previously, another technique
for introducing chromosomes using murine satellite
DNA-based artiﬁcial chromosomes (SATAC) ranging
from 60 to 400Mb was reported (26). SATACs could be
puriﬁed by ﬂow cytometry due to their characteristic
base-pair composition (a greater AT:GC ratio), and
they could be transferred to mammalian cell lines and
primary cells using transfection reagents (27,28). This
puriﬁcation strategy by ﬂow cytometry was specialized
for SATAC and is not applicable to other chromosome
materials, including HACs. The isolation and transfection
strategy using metaphase chromosomes described herein is
likely to be applicable to a variety of cell types, both as
donors and recipients. Transfection eﬃciencies using this
method are comparable to those of MMCT, indicating the
utility of this strategy for the introduction of transgenes.
The mitotic and meiotic stability of human chromo-
somes in mice was previously demonstrated using the
natural chromosome 21 and truncatedmini-chromosomes
that retained native chromosome function (1,29,30). We
have established mouse ES cell lines carrying globin-HAC
using a bottom-up strategy; we then created mice
harbouring the HAC (12). In the current study, we ﬁrst
demonstrated the authentic expression of the transgenes
from the HAC in mice. The behaviour of the human
globin gene locus in transgenic mice is well-studied
(16–22). The natural stage- and tissue-speciﬁc expression
of the e, g and b-globin genes was reproduced from the
human globin cluster on the HAC in hematopoietic
diﬀerentiated cells, mouse embryos, and adult mouse
tissue. In this study, the number of b-globin transgenes
was 12 copies that was not physiological number. While
high copy number of transgenes was useful for detection
of the transgene expression, we need to examine the
expression of b-globin from physiological copy number
using HAC vector system in which we can put one or
two copies of transgenes (13).
We could also manipulate the same globin-HAC in
a human cell culture system. Expression of the g-globin
Figure 5. Expression of the globin genes after a drastic change in host cell type. (a) Scheme for HAC transfer. The globin-HAC was originally
constructed in HT1080 cells, and then transferred to K562 cells by microcell-mediated chromosome transfer via a fusion cell line (HT-A9/globin29).
The globin-HAC in K562/globin29 cells was transferred again to HT1080 and HeLa by transfection. (b) Quantiﬁcation of globin transcripts by
real-time PCR analysis. The histogram shows the quantities (copies/mg RNA) of Gg-globin and Ag-globin transcripts in HT1080 (blue), HT/globin29
(gray), K562 (black) and K562/globin29 (red) cells. (c) Expression of g-globin gene from the globin-HAC in non-erythrocyte cells. Expression of
g-globin genes in 11 cell lines of HT/globin-vK and 7 cell lines of HeLa/globin-vK was analyzed by RT–PCR.
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cells, whereas the g-globin gene was activated in a
cell type-speciﬁc manner when the globin-HAC was
transferred into K562. The g-globin genes both on
original HAC (HT/globin29) and transferred HAC
(HT/globin-vK and HeLa/globin-vK) were repressed as
the same level of endogenous genes in HT1080 and
HeLa cells. However, the b-globin gene, which was
repressed in HT1080 and expressed at low level in K562,
barely expressed in small portion of HT/globin-vK cell
lines (2 lines out of 11) and HeLa/globin-vK cell lines
(1 line out of 7) at the lower level of that in K562 (data
not shown). The low level transcript of b-globin gene in
non-erythrocyte cells could be also detected in case of
transiently transfected DNA or chromatin packaged
HAC, as reported previously (31,32). Expression of the
globin gene locus, repressed in HT1080 cells, was activated
in K562 cells in the absence of the process of diﬀerentia-
tion into adult erythrocyte cells, and was again repressed
in HT1080 and HeLa cells when the HAC was transferred
back from K562 cells. These data suggest that these HACs
could be useful tools to correlate gene regulation with
chromatin epigenetics, by examining DNaseI sensitive
sites, histone modiﬁcation and DNA methylation in the
LCR formed in erythrocyte (K562) and non-erythrocyte
(HT1080 and HeLa) cells. Full control of transgene
expression in mammalian cell systems is very important,
but this is not widely possible bioscience research because
transgene expression is often inﬂuenced by chromatin
structure and there is little methodological control over
the number, integration location, and chromatin structure
of transgenes in host cell chromosomes. The HAC
developed in these studies allowed us to control the expre-
ssion of transgenes in various cell lines. The technology for
manipulating genes packaged into chromatin using HACs
could ﬁnd wide-spread application in basic science,
applied biology, and in regeneration medicine.
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